Enzalutamide With External Beam Radiation for Intermediate Risk Prostate Cancer: A Phase II Study
Latest Information Update: 09 May 2023
At a glance
- Drugs Enzalutamide (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 13 Apr 2023 Status changed from active, no longer recruiting to completed.
- 26 Jul 2021 Planned End Date changed from 1 Jan 2021 to 1 Dec 2021.
- 26 Jul 2021 Planned primary completion date changed from 1 Jun 2021 to 1 Dec 2021.